Contact: European Respiratory Society Press Office
European Respiratory Society
St John's wort as effective as standard antidepressant
St John's wort is as effective as imipramine - one of the most commonly used antidepressants - and should be considered as a first line treatment in patients with mild to moderate depression, according to the largest ever study of St John's wort published this week in the BMJ.
Contact: Emma Wilkinson
BMJ-British Medical Journal
Plant compound blocks action of cancer genes
HHMI researchers have found that a plant compound that produces severe neural defects in developing embryos can block the action of mutated genes that produce basal cell skin carcinomas, the most common form of human cancer.
Contact: Jim Keeley
Howard Hughes Medical Institute
Dual drug treatment prevents formation of colon tumors in
By combining an aspirin-like compound with a drug that inhibits epidermal growth factor activity, HHMI scientists have nearly eliminated pre-cancerous colon polyps in mice that are susceptible to developing colon tumors. The strategy could become a powerful preventive therapy for human colon cancer.
First potential 'universal' cancer vaccine shows promise in
Results from preliminary laboratory studies provide the first functional evidence that developing a 'universal' cancer vaccine might be possible, researchers from Duke University Medical Center and Geron Corp. reported Tuesday.
B cells may help maintain HIV infection
NIAID scientists report for the first time that B cells - the antibody-producing cells of the immune system - help ferry HIV throughout the blood and can likely deliver the virus to nearby T cells. This discovery helps explain several phenomena associated with HIV infection and paves the way for new approaches to eliminating the virus from the blood.
Contact: Sam Perdue
NIH-National Institute of Allergy and Infectious Diseases
Aerosol form of cyclosporine hits key cellular target in lung transplant
patients, researchers report at international meetin
An aerosol spray that delivers the anti-rejection drug cyclosporine directly to transplanted lungs targets an important biological process not seen with other immunosuppressant drugs, including oral cyclosporine. Results from an ongoing clinical study indicate aerosol cyclosporine hinders the pumping mechanism a cell uses to spit out anything deemed undesirable, including drugs.
National Institutes of Health